Purchase Order 75N90023P00735
Award Date 5/1/23
Potential Completion Date 4/30/24
Potential Value $121K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jacksonville Beach, FL 32250, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $115,500 firm fixed-price purchase order to Hematerra Technologies, LLC, a for-profit limited liability company, for maintenance, support, and messaging software for the Clinical Center's blood donor services division. This contract is for the HemaConnect donor system and related HemaComply and HemaControl products, building on prior awards to Hematerra Technologies totaling over $500,000 for...
- The Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract to Hematerra Technologies, LLC, a for-profit limited liability company, for ongoing maintenance and support of the HemaConnect, HemaComply Lab, HemaComply Equipment Manager, and HemaControl software products used in the Clinical Center's blood donor services division. The potential value of this contract is $108,000.00, and it does not have a...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center to Hematerra Technologies, LLC, a for-profit limited liability company. The $124,913.00 contract is for the maintenance and support of Hematerra's software solutions, including HemaConnect, HemaComply, and HemaControl, which support the NIH Clinical Center's blood donor services division. This contract has no set-aside designation and is a...
- The National Institutes of Health Clinical Center has awarded a one-year firm fixed-price purchase order valued at $132,519 to Hematerra Technologies, LLC for preventative maintenance and software support services for the HemaComply equipment suite. The award, effective May 1, 2026 through April 30, 2027, supports critical blood bank operations at the NIH Clinical Center's Department of Transfusion Medicine. The HemaComply system suite, which includes HemaComply-Lab, HemaComply-Equipment...
- This is a firm fixed-price purchase order for $128,660.00 awarded by the National Institutes of Health (NIH) Clinical Center to Hematerra Technologies, LLC, a for-profit limited liability company, for HemaComply software maintenance and support services. The contract has an ultimate completion date of April 30, 2026. Hematerra Technologies provides healthcare technology solutions, including blood donor management, medical device tracking, and inventory management software, to various federal...
- Haemonetics Corporation has been awarded a firm fixed price purchase order contract valued at approximately $22,836 by the Department of Health and Human Services National Institutes of Health Clinical Center. This one-year maintenance agreement is needed by the Department of Laboratory Medicine to support TEG 5000 instruments and will be performed in Bethesda, Maryland. No set-aside designation was applied to this solicitation. Haemonetics Corporation will serve as the prime contractor to...
- This is a $47,000.00 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Haemonetics Corporation, a leading medical technology company. The contract is for a HEMATOLOGY CLINICAL CONSULT COORDINATOR with no set-aside designation, indicating open competition. Haemonetics provides an extensive range of medical devices, consumables, software, and services to federal healthcare agencies, including hemostasis analyzers, blood recovery...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $227,512.10 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, to provide various clinical tests from Clinical Center patients that have undergone hematopoietic stem cell transplant or have myeloid disorders. The contract has an expected completion date of April 26, 2024. Life Technologies Corporation is a division of Thermo Fisher Scientific that...
- This is a $14,644 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Haemonetics Corporation, a leading medical technology company specializing in blood and plasma management products and services. The contract is for the procurement of medical devices, consumables, and related services, including hemostasis analyzers, blood recovery systems, automated cell processors, and associated supplies and reagents. The award has no set-aside designation,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $198,597.49 firm-fixed-price purchase order contract to Life Technologies Corporation, a for-profit manufacturer, to supply specialized reagents and disposables to support the NIH's cellular therapy research and treatment programs. The contract is for a base year with three option years, providing reagents and supplies to enable the processing of approximately 100 cellular therapy...
The Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center awarded a $121,275 firm fixed-price purchase order to Hematerra Technologies, LLC, a for-profit limited liability company, to provide maintenance, support, and messaging software services for the Clinical Center's blood donor services division. The contract, which runs through April 30, 2024, includes services for Hematerra's HemaConnect donor system and related HemaComply and HemaControl products. Over the past three fiscal years, Hematerra has been awarded over $500,000 in federal contracts from the NIH Clinical Center, all designated as prime contracts with no set-aside requirements.
Generated 3/24/24, 2:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $121.3k | 8/23/23 |